Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Prostate Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00706966
What this trial is testing

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

Who this might be right for
Nonmalignant NeoplasmProstate Cancer
University of California, San Francisco 10
Testing effectiveness (Phase 2)Study completedNCT00433446
What this trial is testing

S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 62
Testing effectiveness (Phase 2)Study completedNCT00087139
What this trial is testing

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 124
Early research (Phase 1)Study completedNCT02472275
What this trial is testing

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Stage I Prostate AdenocarcinomaStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Barbara Ann Karmanos Cancer Institute 8
Large-scale testing (Phase 3)Active Not RecruitingNCT01368588
What this trial is testing

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 2,590
Testing effectiveness (Phase 2)Ended earlyNCT00526591
What this trial is testing

Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Jorge A. Garcia, MD 17
Testing effectiveness (Phase 2)Ended earlyNCT03827473
What this trial is testing

Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostatic AdenocarcinomaStage IV Prostate Cancer+2 more
University of Utah 1
Testing effectiveness (Phase 2)Ended earlyNCT01126879
What this trial is testing

Genistein in Treating Patients With Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
Northwestern University 12
Testing effectiveness (Phase 2)Temporarily pausedNCT04519879
What this trial is testing

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Who this might be right for
Prostate AdenocarcinomaPSA FailurePSA Progression+7 more
City of Hope Medical Center 133
Testing effectiveness (Phase 2)Study completedNCT00083005
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03624660
What this trial is testing

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
University of Florida 100
Testing effectiveness (Phase 2)UnknownNCT02525068
What this trial is testing

Enzalutamide in Combination With AZD5363 in Patients With mCRPC

Who this might be right for
Adenocarcinoma of the Prostate
Institute of Cancer Research, United Kingdom 136
Testing effectiveness (Phase 2)Study completedNCT00003307
What this trial is testing

Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer

Who this might be right for
Prostate CancerRadiation Toxicity
University of Arizona 25
Testing effectiveness (Phase 2)Ended earlyNCT00293371
What this trial is testing

Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 6
Early research (Phase 1)Study completedNCT00082732
What this trial is testing

Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT00016107
What this trial is testing

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 72
Large-scale testing (Phase 3)Study completedNCT00869206
What this trial is testing

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Who this might be right for
Breast AdenocarcinomaDS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell Myeloma+4 more
Alliance for Clinical Trials in Oncology 1,822
Early research (Phase 1)Study completedNCT00217516
What this trial is testing

Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 18
Large-scale testing (Phase 3)Study completedNCT00003607
What this trial is testing

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 450
Testing effectiveness (Phase 2)Ended earlyNCT00503984
What this trial is testing

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerPain
University of Miami 22
Next Page